Analyst Ratings for Globe Life
Over the past 3 months, 8 analysts have published their opinion on Globe Life (NYSE:GL) stock. These analysts…
RBC Capital Reiterates Sector Perform on Paysafe, Maintains $36 Price Target
RBC Capital analyst Daniel Perlin reiterates Paysafe (NYSE:PSFE) with a Sector Perform and maintains $36 price target.
HC Wainwright & Co. Reiterates Buy on VYNE Therapeutics – 1-for-18 Reverse Stock Split
HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy, 1-for-18 reverse stock split.
RBC Capital Reiterates Sector Perform on BioCryst Pharma, Maintains $10 Price Target
RBC Capital analyst Brian Abrahams reiterates BioCryst Pharma (NASDAQ:BCRX) with a Sector Perform and maintains $10 price target.
JMP Securities Reiterates Market Outperform on Vacasa, Maintains $3 Price Target
JMP Securities analyst Eric Ross reiterates Vacasa (NASDAQ:VCSA) with a Market Outperform and maintains $3 price target.
RBC Capital Maintains Sector Perform on AcuityAds Holdings, Raises Price Target to C$3.5
RBC Capital analyst Drew McReynolds maintains AcuityAds Holdings (TSX:AT) with a Sector Perform and raises the price target from C$3 to C$3.5.
JMP Securities Reiterates Market Outperform on Inspired Entertainment, Maintains $18 Price Target
JMP Securities analyst Jordan Bender reiterates Inspired Entertainment (NASDAQ:INSE) with a Market Outperform and maintains $18 price target.
JMP Securities Reiterates Market Outperform on Booking Holdings, Maintains $2750 Price Target
JMP Securities analyst Nicholas Jones reiterates Booking Holdings (NASDAQ:BKNG) with a Market Outperform and maintains $2750 price target.
Jim Cramer Is Surprised No One Is Buying This ‘Very Good Bank’ Amid Crash
Shares of First Republic Bank (NYSE: FRC) were rebounding strongly in premarket on Tuesday.
Canaccord Genuity Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $26
Canaccord Genuity analyst Sumant Kulkarni maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $24 to $26.